查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1262029

PCOS 诊断市场全球行业规模、份额、趋势、机会、预测，2018-2028 年，按测试类型、最终用户、地区、竞争

PCOS Diagnostic Market Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F Segmented By Test Type, By End User, By Region and Competition
出版日期: | 出版商: TechSci Research | 英文 112 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

预计全球 PCOS 诊断市场将在预测期内稳步增长。 多囊卵巢综合征病例的增加将支持全球多囊卵巢综合征诊断市场，因为它将增加对有效诊断程序和试剂的需求，为市场带来积极效益。 PCOS 发病率的上升、对早期诊断的需求增加、久坐不动的生活方式的延长以及育龄妇女的肥胖推动了全球多囊卵巢综合征 (PCOS) 诊断市场的显着增长。

PCOS 在育龄妇女中的患病率上升

据称，在全球范围内，PCOS 影响了超过 6%-10% 的育龄妇女。 根据全球疾病负担研究，2017 年，15-49 岁女性的患病率和严重程度占 PCOS 发病率的 155 万（95% 不确定区间）。 2007年和2017年，厄瓜多尔、秘鲁、玻利维亚、日本和百慕大的年龄标化发病率和发病率最高。

在阿联酋女性中也发现了 PCOS 的患病率最高，使其成为该国不孕的主要原因。 同样，德克萨斯女子大学通过诊断方法对 PCOS 患病率进行的一项研究发现，在正式诊断为 PCOS 的人群中患病率为 28.5%，而在未经正式诊断的女性中患病率为 40.5%。这已被证实显示出更高的患病率。

久坐不动的生活方式和人口肥胖率上升

全球女性肥胖的发生率几乎翻了一番，从 6% 增加到 10%。 一项研究发现，肥胖和非肥胖女性的 PCOS 发病率奇比为 2.77。 同样，在西班牙女性中进行的 ClinicalTrials.Gov 结果显示，体重健康的女性患 PCOS 的患病率为 5.5%，而肥胖女性的患病率高出 28.3%。已确认。 由于多囊卵巢综合征最常见的原因是久坐不动的生活方式，多见于居住在城市地区的年轻人，可能是由于适应不良的饮食习惯、缺乏运动和过度压力等不活跃的生活方式所致。 在此背景下，预计 PCOS 诊断市场将在全球范围内出现高需求。

PCOS早期诊断需求增加

据说PCOS极有可能患上胰岛素抵抗、2型糖尿病、高胆固醇、高血压、心脏病、流产/早产、抑郁、焦虑和子宫出血等各种疾病。重要疾病。

根据发表在《环境研究与公共卫生》杂誌上的一项研究，在寻求医疗救助的人群中，PCOS 仍未确诊的比例非常高，高达 75%。估计。 与过量雄激素和月经异常相关的症状对女性的生活质量具有显着的负面影响。 因此，为防止问题恶化，患者应与医生讨论他们的症状，并可能进行进一步检查以避免并发症。 青少年 PCOS 是一个日益严重的健康问题。 因此，早期干预和鼓励健康的生活方式对于预防进一步的发病率是必要的。 根据诊断，医生建议患者使用激素避孕药来降低子宫内膜炎的风险、调节月经、治疗皮肤痤疮和减少多余的体毛。

近期发展

PCOS 宣传月（9 月 1 日至 30 日）

PCOS 宣传月是联邦政府指定的活动，于 9 月举行，旨在传播对患有 PCOS 的女性的认识和支持。 全国多囊卵巢综合症协会赞助了 PCOS 挑战赛，这是最大的非营利宣传和宣传组织，旨在为多囊卵巢综合症患者提供支持。 它为全球超过 55,000 名会员提供服务。 该非营利组织每年通过多个电视和广播节目、在线和离线支持小组、教育、赠款、意识和宣传工作来帮助受 PCOS 影响的人。 提高公众、女孩和妇女对 PCOS 的认识和教育，告知诊断和治疗方案，并推动早期诊断的需求。

可定制

根据市场数据，TechSci Research 根据公司的具体需求提供定制服务。 该报告可以定制为：

公司信息

  • 对其他市场参与者（最多 5 家公司）进行深入分析和概况分析

内容

第 1 章概述

  • 市场定义
  • 市场范围
    • 目标市场
    • 研究目标年份
    • 主要市场细分

第二章研究方法论

  • 调查目的
  • 基线调查方法
  • 主要行业合作伙伴
  • 主要协会和次要信息
  • 调查方法
  • 数据三角测量和验证
  • 假设和限制

第 3 章执行摘要

  • 市场概览
  • 主要市场细分概述
  • 主要市场参与者概览
  • 主要地区/国家概览
  • 市场驱动因素、挑战和趋势

第 4 章 VOC（客户之声）

第5章临床试验分析

  • 正在进行的临床试验
  • 已完成临床试验
  • 已完成临床试验
  • 管道细分（按开发阶段）
  • 管道细分（按状态
  • 管道分解（按测试应用）
  • 按地区划分的渠道细分
  • 临床试验热图

第 6 章 PCOS 诊断的全球市场展望

  • 市场规模和预测
    • 按金额
  • 市场份额和预测
    • 按测试类型（验血、骨盆检查、经阴道超声）
    • 最终用户（医院/诊所、生育诊所、其他）
    • 按地区
    • 按公司分类（2022 年）
  • 产品市场地图
    • 按测试类型
    • 最终用户
    • 按地区

第7章北美PCOS诊断市场展望

  • 市场规模和预测
    • 按金额
  • 市场份额和预测
    • 按测试类型
    • 最终用户
    • 按国家
  • 北美：国家/地区分析
    • 美国
    • 墨西哥
    • 加拿大

第 8 章欧洲 PCOS 诊断市场前景

  • 市场规模和预测
    • 按金额
  • 市场份额和预测
    • 按测试类型
    • 最终用户
    • 按国家
  • 欧洲：国家分析
    • 法国
    • 德国
    • 英国
    • 意大利
    • 西班牙

第 9 章亚太 PCOS 诊断市场展望

  • 市场规模和预测
    • 按金额
  • 市场份额和预测
    • 按测试类型
    • 最终用户
    • 按国家
  • 亚太地区：国家/地区分析
    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳大利亚

第 10 章南美 PCOS 诊断市场前景

  • 市场规模和预测
    • 按金额
  • 市场份额和预测
    • 按测试类型
    • 最终用户
    • 按国家
  • 南美洲：国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第 11 章中东和非洲 PCOS 诊断市场前景

  • 市场规模和预测
    • 按金额
  • 市场份额和预测
    • 按测试类型
    • 最终用户
    • 按国家
  • MEA：国家分析
    • 南非 PCOS 诊断
    • 沙特阿拉伯 PCOS 诊断
    • 阿联酋 PCOS 诊断
    • 科威特 PCOS 诊断

第 12 章市场动态

  • 司机
  • 做

第13章市场趋势与发展

  • 近期趋势
  • 併购
  • 产品发布

第14章竞争格局

  • 业务概览
  • 企业概况
  • 产品和服务
  • 财务（适用于上市公司）
  • 近期发展状况
  • SWOT 分析
    • Siemens Healthineers AG
    • GE Healthcare
    • Mindray Medical International Limited
    • Esaote S.p.A
    • Telemed Medical Systems
    • Shantou Institute of Ultrasonic Instruments Co., Ltd.（SIUI）
    • BK Medical
    • Alpinion Medical Systems
    • Mindray ZONARE Medical Systems
    • Xianfeng Ultrasound Medical

第 15 章战略建议

简介目录
Product Code: 14692

Global PCOS Diagnostic Market is expected to grow at a steady rate over the forecast period. The growing prevalence of polycystic ovarian syndrome will support the global Polycystic Ovarian Syndrome Diagnostic market, as the increased cases of PCOS will elevate the demand for effective diagnostic procedures and medications, thus benefitting the market positively. The growing PCOS occurrence, increased demand for early diagnosis, extended sedentary lifestyle, and obesity among women of reproductive age will help the polycystic ovarian syndrome (PCOS) diagnostic market to grow significantly around the globe.

Polycystic Ovarian Syndrome (PCOS) is a condition arising due to hormonal imbalance affecting women of childbearing age. It is a symptomatic disorder characterized by irregular or no periods and increased levels of male hormones in the body. According to the Centers for Disease Control and Prevention, approximately 5 million women of reproductive age in the United States have a polycystic ovarian syndrome. The rise in cases will hence directly offer opportunities for the PCOS diagnostic market to grow significantly over the forecast period.

Rising Prevalence of PCOS Among Females of Reproductive Age

Globally, PCOS affects over 6% -10% of women of reproductive age. According to the Global Burden of Disease study, in 2017, prevalence, as well as the severity of problems among women of age 15-49 years, accounted for 1.55 million (95% uncertainty intervals) incident cases of PCOS. In the years 2007 and 2017, the highest age-standardized incidences and disease occurrence rates were observed in Ecuador, Peru, Bolivia, Japan, and Bermuda.

Also, the highest prevalence of PCOS is found to be among women in UAE and is a leading cause of infertility in the country. Similarly, according to a research study performed by Texas Woman's University to record the prevalence of PCOS based on the diagnosis method, it was observed that 28.5% of the PCOS prevalence was indicated for formally diagnosed PCOS respondents, and a larger account of prevalence, i.e., around 40.5% was indicated among those women without a formal diagnosis.

Sedentary Lifestyle and Increasing Cases of Obesity Among the Population

The increasing rate of occurrence of obesity among women has almost doubled, i.e., from 6% -10% around the globe. A study revealed that there is an odd ratio of 2.77 for the development of PCOS among obese women and their non-obese women counterparts. Similarly, According to ClinicalTrials.Gov results based on a study conducted among women in Spain, it was observed that there were ~28.3% more chances of PCOS in obese women, compared to a 5.5% prevalence of PCOS among healthy-weighted women. A sedentary lifestyle is the most common cause of PCOS and is therefore observed most in the younger generation among the urban population due to increased bad eating habits and inactive lifestyle adaptation such as no physical exercise and excessive stress. This aspect is propelling the PCOS diagnostic market for higher demand across the globe.

Increase in Demand for Early Diagnosis Of PCOS

Since PCOS has been associated with a higher chance of acquiring several illnesses, such as insulin resistance, type 2 diabetes, high cholesterol, high blood pressure, heart disease, miscarriage or premature birth, depression, anxiety, bleeding from the uterus, etc., therefore, early detection of the condition is highly crucial.

According to a research study published in Environmental Research and Public health journal, PCOS has a very high percentage of individuals who remained undiagnosed when visiting their doctor, which is a number estimated to be as high as 75%. The symptoms linked to excess androgen and abnormalities in periods have a significant negative impact on women's quality of life. Therefore, in order to prevent the problem from getting worse, the patient should consult a doctor about their symptoms and possibly pursue further testing to avoid complications. Adolescent PCOS is a growing health concern. Thus, early interventions and the encouragement of healthy lifestyles are required to prevent additional morbidities. In accordance with the diagnosis, the doctor may advise the patient to use hormonal birth control pills to reduce the risk of endometrial instances, regulate the period, treat skin acne, and reduce excess body hair.

Recent Developments

PCOS Awareness Month (1September - 30 September)

PCOS awareness month is a federally designated event, which is organized in September month and inaugurated as an initiative for spreading awareness and support among women suffering from PCOS. The National Polycystic Ovary Syndrome Association is sponsoring the largest non-profit support and advocacy organization PCOS Challenge, established to provide support to people with the polycystic ovarian syndrome. It serves over 55,000 members across the globe. This non-profit organization supports PCOS-affected individuals each year through several television and radio programming, online and offline support groups, education, grants, awareness, and advocacy initiatives. By increasing awareness & education about PCOS among the general public, girls, and women, they provide information on diagnosis and treatment options, thereby promoting the need for early diagnosis.

Market Segmentation

The global PCOS Diagnosis market can be segmented on the test type, end user, and region. Based on the test type, the market can be segmented into Blood tests, pelvic exams, and Transvaginal ultrasounds. Depending on the end user, the market can be segmented into Hospitals & Clinics, Fertility Clinics, and Others.

Market Players

Siemens Healthineers AG, GE Healthcare, Mindray Medical International Limited, Esaote S.p.A, Telemed Medical Systems, Shantou Institute of Ultrasonic Instruments Co., Ltd. (SIUI), BK Medical, Alpinion Medical Systems, Mindray ZONARE Medical Systems, Xianfeng Ultrasound Medical are some of the leading companies operating in the market.

Report Scope

In this report, Global PCOS Diagnostic Market, the market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

PCOS Diagnostic Market, By Test Type:

  • Blood tests
  • Pelvic exam
  • Ultrasound (Transvaginal)

PCOS Diagnostic Market, By End User:

  • Hospitals & Clinics
  • Fertility clinics
  • Others

PCOS Diagnostic Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • Italy
    • Spain
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • South Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global PCOS Diagnostic Market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Clinical Trial Analysis

  • 5.1. Ongoing Clinical Trials
  • 5.2. Completed Clinical Trials
  • 5.3. Terminated Clinical Trials
  • 5.4. Breakdown of Pipeline, By Development Phase
  • 5.5. Breakdown of Pipeline, By Status
  • 5.6. Breakdown of Pipeline, By Study Application
  • 5.7. Breakdown of Pipeline, By Region
  • 5.8. Clinical Trials Heat Map

6. Global PCOS Diagnosis Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Test Type (Blood test, Pelvic exam, Transvaginal Ultrasound)
    • 6.2.2. By End Users (Hospitals & Clinics, Fertility Clinics, Others)
    • 6.2.3. By Region
    • 6.2.4. By Company (2022)
  • 6.3. Product Market Map
    • 6.3.1. By Test Type
    • 6.3.2. By End Users
    • 6.3.3. By Region

7. North America PCOS Diagnosis Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Test Type
    • 7.2.2. By End Users
    • 7.2.3. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States PCOS Diagnosis Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Test Type
        • 7.3.1.2.2. By End Users
    • 7.3.2. Mexico PCOS Diagnosis Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Test Type
        • 7.3.2.2.2. By End Users
    • 7.3.3. Canada PCOS Diagnosis Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Test Type
        • 7.3.3.2.2. By End Users

8. Europe PCOS Diagnosis Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Test Type
    • 8.2.2. By End Users
    • 8.2.3. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France PCOS Diagnosis Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Test Type
        • 8.3.1.2.2. By End Users
    • 8.3.2. Germany PCOS Diagnosis Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Test Type
        • 8.3.2.2.2. By End Users
    • 8.3.3. United Kingdom PCOS Diagnosis Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Test Type
        • 8.3.3.2.2. By End Users
    • 8.3.4. Italy PCOS Diagnosis Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Test Type
        • 8.3.4.2.2. By End Users
    • 8.3.5. Spain PCOS Diagnosis Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Test Type
        • 8.3.5.2.2. By End Users

9. Asia-Pacific PCOS Diagnosis Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Test Type
    • 9.2.2. By End Users
    • 9.2.3. By Country
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. China PCOS Diagnosis Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Test Type
        • 9.3.1.2.2. By End Users
    • 9.3.2. India PCOS Diagnosis Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Test Type
        • 9.3.2.2.2. By End Users
    • 9.3.3. South Korea PCOS Diagnosis Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Test Type
        • 9.3.3.2.2. By End Users
    • 9.3.4. Japan PCOS Diagnosis Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Test Type
        • 9.3.4.2.2. By End Users
    • 9.3.5. Australia PCOS Diagnosis Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Test Type
        • 9.3.5.2.2. By End Users

10. South America PCOS Diagnosis Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Test Type
    • 10.2.2. By End Users
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil PCOS Diagnosis Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Test Type
        • 10.3.1.2.2. By End Users
    • 10.3.2. Argentina PCOS Diagnosis Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Test Type
        • 10.3.2.2.2. By End Users
    • 10.3.3. Colombia PCOS Diagnosis Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Test Type
        • 10.3.3.2.2. By End Users

11. Middle East and Africa PCOS Diagnosis Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Test Type
    • 11.2.2. By End Users
    • 11.2.3. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa PCOS Diagnosis Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Test Type
        • 11.3.1.2.2. By End Users
    • 11.3.2. Saudi Arabia PCOS Diagnosis Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Test Type
        • 11.3.2.2.2. By End Users
    • 11.3.3. UAE PCOS Diagnosis Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Test Type
        • 11.3.3.2.2. By End Users
    • 11.3.4. Kuwait PCOS Diagnosis Market Outlook
      • 11.3.4.1. Market Size & Forecast
        • 11.3.4.1.1. By Value
      • 11.3.4.2. Market Share & Forecast
        • 11.3.4.2.1. By Test Type
        • 11.3.4.2.2. By End Users

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

  • 13.1. Recent Developments
  • 13.2. Mergers & Acquisitions
  • 13.3. Product Launches

14. Competitive Landscape

  • 14.1. Business Overview
  • 14.2. Company Snapshot
  • 14.3. Products & Services
  • 14.4. Financials (In Case of Listed Companies)
  • 14.5. Recent Developments
  • 14.6. SWOT Analysis
    • 14.6.1. Siemens Healthineers AG
    • 14.6.2. GE Healthcare
    • 14.6.3. Mindray Medical International Limited
    • 14.6.4. Esaote S.p.A
    • 14.6.5. Telemed Medical Systems
    • 14.6.6. Shantou Institute of Ultrasonic Instruments Co., Ltd. (SIUI)
    • 14.6.7. BK Medical
    • 14.6.8. Alpinion Medical Systems
    • 14.6.9. Mindray ZONARE Medical Systems
    • 14.6.10. Xianfeng Ultrasound Medical

15. Strategic Recommendations